Antiviral Research

Hepatitis C virus NS3/4A protease
pp. 1-18(18)
Authors: Kwong A.D.; Kim J.L.; Rao G.; Lipovsek D.; Raybuck S.A.

Recent advances in l-nucleosides: chemistry and biology
pp. 19-44(26)
Authors: Wang P.; Hong J.H.; Cooperwood J.S.; Chu C.K.

Adenovirus endopeptidase and papain are inhibited by the same agents
pp. 45-51(7)
Authors: Sircar S.; Ruzindana-Umunyana A.; Neugebauer W.; Weber J.M.

Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir
pp. 53-56(4)
Authors: Neyts J.; De Clercq E.

Therapeutic evaluation of compounds in the SCID-RA papillomavirus model
pp. 57-71(15)
Authors: Lobe D.C.; Kreider J.W.; Phelps W.C.

Comparison of antiviral compounds against human herpesvirus 6 and 7
pp. 73-84(12)
Authors: Yoshida M.; Yamada M.; Tsukazaki T.; Chatterjee S.; Lakeman F.D.; Nii S.; Whitley R.J.

The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process
pp. 85-94(10)
Authors: Pope L.E.; Marcelletti J.F.; Katz L.R.; Lin J.Y.; Katz D.H.; Parish M.L.; Spear P.G.

Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant
pp. 95-103(9)
Authors: Faizi Khan R.; Mori S.; Eizuru Y.; Kumura Ishii K.; Minamishima Y.

Solid phase ELISA for determination of the virus dose dependant sensitivity of human cytomegalovirus to antiviral drugs in vitro
pp. 105-112(8)
Authors: Ljungdahl Stahle E.; Schloss L.; Sundqvist V.-A.; Brytting M.; Hokeberg I.; Cox S.; Wahren B.; Linde A.